Livsmed Inc (KOSDAQ:491000)
51,700
+5,450 (11.78%)
At close: Dec 30, 2025
Livsmed Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 5,698 | 16,815 | 8,019 | 14,911 |
Short-Term Investments | 7,000 | - | 32,000 | - |
Cash & Short-Term Investments | 12,698 | 16,815 | 40,019 | 14,911 |
Cash Growth | -68.27% | -57.98% | 168.39% | - |
Accounts Receivable | 25,634 | 14,644 | 7,722 | 3,937 |
Other Receivables | 187.1 | 72 | 356.21 | 159.98 |
Receivables | 25,869 | 14,764 | 8,126 | 4,145 |
Inventory | 10,153 | 4,283 | 3,793 | 2,926 |
Prepaid Expenses | - | 224.3 | 128.67 | 79.28 |
Other Current Assets | 2,691 | 1,534 | 570.45 | 114.74 |
Total Current Assets | 51,411 | 37,620 | 52,638 | 22,176 |
Property, Plant & Equipment | 18,143 | 11,763 | 5,142 | 3,668 |
Long-Term Investments | - | 0 | - | -0 |
Other Intangible Assets | 1,353 | 1,079 | 846.07 | 742.94 |
Other Long-Term Assets | 3,454 | 2,796 | 1,211 | 675.37 |
Total Assets | 74,361 | 53,258 | 60,396 | 27,821 |
Accounts Payable | - | 1,290 | 1,326 | 848.48 |
Accrued Expenses | - | 555.34 | 292.5 | 308.04 |
Short-Term Debt | 5,000 | 3,000 | 3,000 | 4,900 |
Current Portion of Leases | 1,311 | 1,037 | 573.91 | 563.48 |
Other Current Liabilities | 8,314 | 3,056 | 142,199 | 177,043 |
Total Current Liabilities | 14,626 | 8,938 | 147,392 | 183,663 |
Long-Term Leases | 5,945 | 4,442 | 1,641 | 1,761 |
Pension & Post-Retirement Benefits | - | - | - | 1,877 |
Other Long-Term Liabilities | 205.26 | 274.36 | 332.66 | 598.46 |
Total Liabilities | 20,776 | 13,654 | 149,365 | 187,899 |
Common Stock | 11,084 | 10,723 | 8,281 | 65.1 |
Additional Paid-In Capital | 315,798 | 289,165 | 113,029 | 1,522 |
Retained Earnings | -290,224 | -273,028 | -247,443 | -190,266 |
Comprehensive Income & Other | 16,927 | 12,744 | 9,003 | 4,936 |
Total Common Equity | 53,585 | 39,604 | -117,131 | -183,743 |
Shareholders' Equity | 53,585 | 39,604 | -88,969 | -160,079 |
Total Liabilities & Equity | 74,361 | 53,258 | 60,396 | 27,821 |
Total Debt | 12,256 | 8,479 | 5,214 | 7,225 |
Net Cash (Debt) | 442.32 | 8,336 | 34,804 | 7,686 |
Net Cash Growth | -98.73% | -76.05% | 352.82% | - |
Net Cash Per Share | 21.19 | 498.85 | 2456.31 | 598.79 |
Filing Date Shares Outstanding | 22.17 | 21.45 | 16.56 | 12.84 |
Total Common Shares Outstanding | 22.17 | 21.45 | 16.56 | 12.84 |
Working Capital | 36,786 | 28,682 | -94,754 | -161,487 |
Book Value Per Share | 2417.15 | 1846.69 | -7072.26 | -14314.72 |
Tangible Book Value | 52,232 | 38,524 | -117,977 | -184,486 |
Tangible Book Value Per Share | 2356.10 | 1796.38 | -7123.35 | -14372.60 |
Land | 733 | 733 | 733 | - |
Buildings | 351.93 | 351.93 | 351.93 | - |
Machinery | 9,812 | 5,429 | 2,734 | 1,780 |
Construction In Progress | 2,865 | 1,179 | 43.08 | 14.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.